India reviews drug imports: Over 65 patented therapies flagged; agencies seek key cancer, diabetes and cardiac drugs

The government is considering allowing global tenders for essential patented medicines, including treatments for obesity, cancer, and diabetes, to address shortages in India. This move aims to ensure timely access to critical drugs for central healthcare agencies like the armed forces and ESIS, potentially expanding exemptions from domestic sourcing rules.